相关实验视频
Updated: Jan 14, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
RASSF1A及其在生殖尿路癌症中的表观遗传失调:当前的更新
Sandeep Appunni1,2, Vivek Anand1,3, Madhuram Khandelwal1,4
1Department of Biochemistry, All India Institute of Medical Sciences, Room No. 3015, New Delhi, India.
瘤抑制剂RASSF1A在生殖尿路癌症中经常被过甲基化使得沉默. 评估RASSF1A甲基化有助于诊断,并建议新的治疗策略,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 拉斯夫1A作为瘤抑制剂,经常在尿生殖系统恶性瘤中表达不够.
- 通过RASSF1A CpG岛屿的高甲基化进行表观遗传失活化是一种常见的机制.
- 泌尿生殖系统癌症导致显著的发病率和死亡率,需要新的治疗点.
研究的目的:
- 调查RASSF1A在生殖尿道癌症中的作用.
- 探索RASSF1A甲基化作为诊断和预后生物标志物.
- 评估RASSF1A重新激活作为治疗策略的潜力.
主要方法:
- 在生殖尿道癌样本中分析RASSF1A促进体甲基化状态.
- RASSF1A甲基化与临床参数和患者预后的相关性.
- 研究RASSF1A在像河马信号传递这样的信号通路中的作用.
主要成果:
- 低调RASSF1A与膀癌中的Hippo通路调节有关.
- 在男性生殖系统癌症和前列腺癌中观察到RASSF1A高甲基化.
- RASSF1A高甲基化与尿生殖系统恶性瘤的预后不佳相关.
结论:
- RASSF1A促进物甲基化是生殖尿路癌症的一个重要因素.
- 评估RASSF1A甲基化与其他瘤抑制剂一起可以提高诊断准确度.
- 用低甲基化剂向RASSF1A促进体可能提供一种新的治疗方法.
更多相关视频
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
相关概念视频
The Ras Gene
Ras is a...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity: